These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11121793)

  • 1. Vasoactive intestinal peptide: cardiovascular effects.
    Henning RJ; Sawmiller DR
    Cardiovasc Res; 2001 Jan; 49(1):27-37. PubMed ID: 11121793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagal nerve stimulation during muscarinic and beta-adrenergic blockade causes significant coronary artery dilation.
    Feliciano L; Henning RJ
    J Auton Nerv Syst; 1998 Jan; 68(1-2):78-88. PubMed ID: 9531447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow.
    Feliciano L; Henning RJ
    Cardiovasc Res; 1998 Oct; 40(1):45-55. PubMed ID: 9876316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate.
    Henning RJ; Feliciano L; Coers CM
    Cardiovasc Res; 1996 Nov; 32(5):846-53. PubMed ID: 8944815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate.
    Henning RJ
    J Auton Nerv Syst; 1992 Sep; 40(2):121-9. PubMed ID: 1464693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations.
    Karasawa Y; Furukawa Y; Ren LM; Takei M; Murakami M; Narita M; Chiba S
    Eur J Pharmacol; 1990 Oct; 187(1):9-17. PubMed ID: 2272357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial and gastrointestinal release of vasoactive intestinal peptide during experimental acute myocardial infarction.
    Gyöngyösi M; Kaszaki J; Németh J; Wolfárd A; Mojzes L; Farkas A
    Coron Artery Dis; 1997 Jun; 8(6):335-41. PubMed ID: 9347213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of vasoactive intestinal peptide and neuropeptide Y from canine heart.
    Anderson FL; Kralios AC; Reid B; Hanson GR
    Am J Physiol; 1993 Sep; 265(3 Pt 2):H959-65. PubMed ID: 8214133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide.
    Popma JJ; Smitherman TC; Bedotto JB; Eichhorn EJ; Said SI; Dehmer GJ
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):1000-6. PubMed ID: 1704974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence and co-localization of vasoactive intestinal polypeptide with neuronal nitric oxide synthase in cells and nerve fibers within guinea pig intrinsic cardiac ganglia and cardiac tissue.
    Parsons RL; Locknar SA; Young BA; Hoard JL; Hoover DB
    Cell Tissue Res; 2006 Feb; 323(2):197-209. PubMed ID: 16220273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence and actions of vasoactive intestinal peptide in the isolated rabbit heart.
    Accili EA; Buchan AM; Kwok YN; Ledsome JR; Brown JC
    Can J Physiol Pharmacol; 1995 Jan; 73(1):134-9. PubMed ID: 7541311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries.
    González C; Barroso C; Martín C; Gulbenkian S; Estrada C
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):977-84. PubMed ID: 9307611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin.
    Anderson FL; Kralios AC; Hershberger R; Bristow MR
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):365-71. PubMed ID: 2464111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide: vasodilatation and cyclic AMP generation.
    Ganz P; Sandrock AW; Landis SC; Leopold J; Gimbrone MA; Alexander RW
    Am J Physiol; 1986 May; 250(5 Pt 2):H755-60. PubMed ID: 3010741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography.
    Barnes PJ; Cadieux A; Carstairs JR; Greenberg B; Polak JM; Rhoden K
    Br J Pharmacol; 1986 Sep; 89(1):157-62. PubMed ID: 3026543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.
    Unverferth DV; O'Dorisio TM; Muir WW; White J; Miller MM; Hamlin RL; Magorien RD
    J Lab Clin Med; 1985 Nov; 106(5):542-50. PubMed ID: 4056568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro chronotropic and inotropic effects of vasoactive intestinal peptide (VIP) on the atria and ventricular papillary muscle from Cynomolgus monkey heart.
    De Neef P; Robberecht P; Chatelain P; Waelbroeck M; Christophe J
    Regul Pept; 1984 Apr; 8(3):237-44. PubMed ID: 6463285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs.
    Anderson FL; Kralios AC; Hershberger R; Bristow MR
    Am J Physiol; 1988 Sep; 255(3 Pt 2):H601-7. PubMed ID: 2843056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.